Listing date for capital increase shares amended
EDGC
245620
Signal Score
Historical Avg Return (5d)
+0.22%
Data Coverage
100%n=2507
Risk-adjusted indicator based on 2507 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Previous Listing Date: June 1, 2026
- • Amended Listing Date: June 2, 2026
- • Court Approval Date: March 20, 2026
AI Analysis Summary
Eone Diagnomics Genome Center Co., Ltd. announced an amendment to its Material Fact Report regarding a paid-in capital increase. The new listing date for the new shares is June 2, 2026, a one-day delay from the original June 1, 2026, due to administrative procedures with the Korea Securities Depository. This capital increase is part of a court-approved rehabilitation plan from March 20, 2026, involving a third-party allocation debt-to-equity swap and stock consolidation. No new cash payments are involved, as the capital increase is for converting approved debt into shares. The impact is neutral as it's a procedural change within a rehabilitation plan.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.